## query.q: KMT2A-MLLT1 ## query.defType: edismax ## query.indent: True ## query.qf: ac^16 id^16 sy^8 text ## query.fl: ac ## query.pf: ac^160 id^160 sy^80 text ## query.start: 0 ## query.q.op: AND ## query.sort: score desc ## query.rows: 1000 ## query.wt: json ## query.fields: (None) ## query.format: txt ## QTime: 1 ## response.numFound: 11 ID M9-ENL1 AC CVCL_A8IE SY M9 ENL1; M9ENL1 DR GEO; GSM838434 DR GEO; GSM838435 DR GEO; GSM838436 DR Wikidata; Q107115912 RX PubMed=22160482; CC Characteristics: Expresses a transfected KMT2A-MLLT1 (MLL-ENL) fusion protein. Mimics the features of primary human pro-B cell acute lymphoblastic leukemia (PubMed=22160482). CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion). CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion). CC Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. CC Transformant: KMT2A-MLLT1. CC Omics: Transcriptomics; Microarray. CC Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. OX NCBI_TaxID=9606; ! Homo sapiens (Human) AG <1D CA Transformed cell line DT Created: 20-05-21; Last updated: 14-08-25; Version: 9 // ID PICALM6B AC CVCL_B3QW DR Wikidata; Q110433137 RX PubMed=26075887; CC Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm. CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion). CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion). CC Transformant: KMT2A-MLLT1. CC Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107. OX NCBI_TaxID=10090; ! Mus musculus (Mouse) SX Sex unspecified AG 14FD CA Transformed cell line DT Created: 16-12-21; Last updated: 19-12-24; Version: 6 // ID PICALM6D AC CVCL_B3QX DR Wikidata; Q110433138 RX PubMed=26075887; CC Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm. CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion). CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion). CC Transformant: KMT2A-MLLT1. CC Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107. OX NCBI_TaxID=10090; ! Mus musculus (Mouse) SX Sex unspecified AG 14FD CA Transformed cell line DT Created: 16-12-21; Last updated: 19-12-24; Version: 6 // ID PICALM6A AC CVCL_B3QV DR Wikidata; Q110433136 RX PubMed=26075887; CC Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm. CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion). CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion). CC Transformant: KMT2A-MLLT1. CC Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107. CC Breed/subspecies: fit1 Picalmfit1-5R. OX NCBI_TaxID=10090; ! Mus musculus (Mouse) SX Sex unspecified AG 14FD CA Transformed cell line DT Created: 16-12-21; Last updated: 19-12-24; Version: 6 // ID HB11;19 AC CVCL_8227 SY HB(11;19); HB11.19; HB 11;19; HB1119 DR EFO; EFO_0022450 DR cancercelllines; CVCL_8227 DR Cell_Model_Passport; SIDM01428 DR DepMap; ACH-001736 DR Wikidata; Q54881357 RX PubMed=1423624; RX PubMed=16523483; CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=1423624; PubMed=16523483; DepMap=ACH-001736). CC Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (DepMap=ACH-001736). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Met (c.374C>T); ClinVar=VCV000183748; Zygosity=Unspecified (DepMap=ACH-001736). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (DepMap=ACH-001736). CC Omics: Genomics; Whole exome sequencing. CC Omics: Variations; Array-based CGH. DI NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged DI ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Sex unspecified AG Age unspecified CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 22 // ID Kasumi-10 AC CVCL_8485 SY KASUMI-10 DR GEO; GSM4254138 DR GEO; GSM5137757 DR JCRB; JCRB1410 DR PRIDE; PXD023662 DR Wikidata; Q54899515 RX PubMed=32180206; RX PubMed=35354797; CC Population: Japanese and Korean. CC Karyotypic information: While originating from a female patient, it has a XXY karyotype that could be explained by a disorder of sexual development (PubMed=32180206). CC Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=32180206; PubMed=35354797). CC Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=32180206). CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Miscellaneous: STR profile from personal communication of Leo, Isabelle Rose. ST Source(s): JCRB=JCRB1410; Direct_author_submission ST Amelogenin: X,Y ST CSF1PO: 11,12 ST D10S1248: 12,15 ST D12S391: 18,22 ST D13S317: 8,11 ST D16S539: 9,10 ST D18S51: 13 ST D19S433: 15.2,16 ST D1S1656: 15,17 ST D21S11: 30 ST D22S1045: 15,17 ST D2S1338: 19,24 ST D2S441: 11,11.3 ST D3S1358: 15,16 ST D5S818: 10,12 ST D7S820: 8,10 ST D8S1179: 13,14 ST DYS391: 9 ST FGA: 22,27.2 ST SE33: 20,26.2 ST TH01: 6,9 ST TPOX: 11,12 ST vWA: 17,19 DI NCIt; C9140; Childhood B acute lymphoblastic leukemia DI NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged DI ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 6M CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 22 // ID KOCL-51 AC CVCL_6865 SY KOCL51 DR Cosmic; 1037749 DR Cosmic; 2391173 DR IARC_TP53; 28413 DR Wikidata; Q54900283 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=1465024; RX PubMed=8180386; RX PubMed=9529133; RX PubMed=9738977; RX PubMed=10360377; RX PubMed=10995006; RX PubMed=14671638; RX PubMed=20519628; RX PubMed=20575032; RX PubMed=28569787; RX PubMed=29786757; RX PubMed=35124168; CC Population: Japanese. CC Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=28569787). DI NCIt; C9140; Childhood B acute lymphoblastic leukemia DI NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged DI ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 3M CA Cancer cell line DT Created: 04-04-12; Last updated: 19-12-24; Version: 22 // ID KOPN-1 AC CVCL_3937 SY Kopn-1; KOPN1 DR BTO; BTO_0004944 DR cancercelllines; CVCL_3937 DR Cosmic; 996302 DR Cosmic; 1037721 DR Cosmic; 2391172 DR IARC_TP53; 28407 DR Wikidata; Q54900299 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=1465024; RX PubMed=8180386; RX PubMed=9738977; RX PubMed=10360377; RX PubMed=14504097; RX PubMed=14671638; RX PubMed=15843827; RX PubMed=20519628; RX PubMed=20575032; RX PubMed=28569787; RX PubMed=29786757; RX PubMed=31305009; RX PubMed=35124168; CC Population: Japanese. CC Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=14671638; PubMed=15843827). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=20575032). CC Omics: Phenotyping; Drug screening. CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. DI NCIt; C9140; Childhood B acute lymphoblastic leukemia DI NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged DI ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 9M CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 25 // ID KOCL-33 AC CVCL_3991 SY KOCL33; KOCL 33; Kocl-33 DR BTO; BTO_0004937 DR Cosmic; 996295 DR Cosmic; 1037745 DR Cosmic; 2391170 DR IARC_TP53; 28409 DR Wikidata; Q54900278 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=1465024; RX PubMed=8180386; RX PubMed=9529133; RX PubMed=9738977; RX PubMed=10360377; RX PubMed=10995006; RX PubMed=14504097; RX PubMed=14671638; RX PubMed=15843827; RX PubMed=20519628; RX PubMed=20575032; RX PubMed=28569787; RX PubMed=29786757; RX PubMed=31305009; RX PubMed=35124168; CC Population: Japanese. CC Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=14671638; PubMed=15843827). CC Omics: Phenotyping; Drug screening. DI NCIt; C9140; Childhood B acute lymphoblastic leukemia DI NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged DI ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 11M CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 25 // ID IMS-M1 AC CVCL_A623 SY IMS/M1; IMS/MI; IMS-MI DR Cosmic; 787437 DR Cosmic; 975256 DR Cosmic; 996321 DR Cosmic; 1037672 DR Cosmic; 1281319 DR Cosmic; 2089654 DR Cosmic; 2378128 DR Wikidata; Q54897680 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=8180386; RX PubMed=8414510; RX PubMed=14504097; RX PubMed=14671638; RX PubMed=23955599; CC Population: Japanese. CC Characteristics: CSF2 dependent. CC Doubling time: 36-48 hours (DOI=10.1016/B978-0-12-221970-2.50457-5). CC Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=14671638). CC Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. DI NCIt; C9154; Adult acute myeloid leukemia DI ORDO; Orphanet_519; Acute myeloid leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 33Y CA Cancer cell line DT Created: 06-06-12; Last updated: 19-12-24; Version: 15 // ID KOPN-8 AC CVCL_1866 SY Kopn-8; KOPN8 DR CLO; CLO_0037178 DR EFO; EFO_0022428 DR ArrayExpress; E-MTAB-2770 DR ArrayExpress; E-MTAB-3610 DR ArrayExpress; E-MTAB-7721 DR ArrayExpress; E-MTAB-7722 DR BioSample; SAMN03473535 DR BioSample; SAMN10988515 DR cancercelllines; CVCL_1866 DR Cell_Model_Passport; SIDM01034 DR ChEMBL-Cells; CHEMBL4295381 DR ChEMBL-Targets; CHEMBL4296456 DR Cosmic; 998710 DR Cosmic; 999747 DR Cosmic; 1037722 DR Cosmic; 1130256 DR Cosmic; 1191708 DR Cosmic; 2491068 DR Cosmic; 2542838 DR Cosmic-CLP; 1330933 DR DepMap; ACH-001106 DR DSMZ; ACC-552 DR DSMZCellDive; ACC-552 DR EGA; EGAS00001000978 DR GDSC; 1330933 DR GEO; GSM887234 DR GEO; GSM888308 DR GEO; GSM1670000 DR GEO; GSM5137722 DR GEO; GSM5137766 DR IARC_TP53; 28230 DR LiGeA; CCLE_069 DR LINCS_LDP; LCL-1088 DR PharmacoDB; KOPN8_779_2019 DR PRIDE; PXD023662 DR PRIDE; PXD030304 DR Progenetix; CVCL_1866 DR PubChem_Cell_line; CVCL_1866 DR Wikidata; Q54900325 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=2985879; RX PubMed=3159941; RX PubMed=3874327; RX PubMed=9067587; RX PubMed=9680106; RX PubMed=10233379; RX PubMed=14671638; RX PubMed=22460905; RX PubMed=26589293; RX PubMed=27397505; RX PubMed=28196595; RX PubMed=30285677; RX PubMed=30629668; RX PubMed=30894373; RX PubMed=31068700; RX PubMed=31160637; RX PubMed=35354797; RX PubMed=35839778; WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Part of: LL-100 blood cancer cell line panel. CC Part of: MD Anderson Cell Lines Project. CC Population: Japanese. CC Doubling time: ~48 hours (DSMZ=ACC-552). CC HLA typing: A*33:03,33:03; B*44:03,44:03; C*14:03,14:03 (PubMed=26589293). CC HLA typing: A*33:03:01,33:03:01; B*44:03:01,44:03:01; C*14:03,14:03; DPA1*01:03:01,02:02:02; DPB1*04:01:01,02:01:02; DQA1*01:02:01,01:02:01; DQB1*06:09:01,06:09:01; DRA*01:02:02,01:02:02; DRB1*13:02:01,13:02:01 (DSMZCellDive=ACC-552). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=31160637; PubMed=35354797; DSMZ=ACC-552). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=1330933; DepMap=ACH-001106). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=1330933; DepMap=ACH-001106). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=3.7%; Native American=0%; East Asian, North=80.77%; East Asian, South=13.03%; South Asian=0%; European, North=0%; European, South=2.49% (PubMed=30894373). CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. ST Source(s): Cosmic-CLP=1330933; DSMZ=ACC-552 ST Amelogenin: X ST CSF1PO: 10,12 ST D13S317: 8,11 ST D16S539: 9,11 ST D18S51: 14,22 ST D19S433: 13,14 ST D21S11: 29 ST D2S1338: 20,23 ST D3S1358: 15,16 ST D5S818: 9,11 ST D7S820: 8,10 ST D8S1179: 13,16 ST FGA: 18,21 ST Penta D: 12,13 ST Penta E: 12,20 ST TH01: 6,10 ST TPOX: 8,11 ST vWA: 16,18 DI NCIt; C9140; Childhood B acute lymphoblastic leukemia DI NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged DI ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 3M CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 39 // RX PubMed=26075887; DOI=10.1371/journal.pone.0129776; PMCID=PMC4467867; RA Mercer, Jacob L. RA Argus, Joseph P. RA Crabtree, Donna Marlana RA Keenan, Melissa M. RA Wilks, Moses Q. RA Chi, Jen-Tsan Ashley RA Bensinger, Steven J. RA Lavau, Catherine P. RA Wechsler, Daniel S. RT "Modulation of PICALM levels perturbs cellular cholesterol RT homeostasis."; RL PLoS ONE 10:e0129776.1-e0129776.20(2015). // RX PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2; RA Matsuo, Yoshinobu RA Drexler, Hans Gunther RT "Establishment and characterization of human B cell precursor-leukemia RT cell lines."; RL Leuk. Res. 22:567-579(1998). // RX PubMed=14504097; DOI=10.1182/blood-2003-02-0418; RA Taketani, Takeshi RA Taki, Tomohiko RA Sugita, Kanji RA Furuichi, Yoshiyuki RA Ishii, Eiichi RA Hanada, Ryoji RA Tsuchida, Masahiro RA Sugita, Kenichi RA Ida, Kohmei RA Hayashi, Yasuhide RT "FLT3 mutations in the activation loop of tyrosine kinase domain are RT frequently found in infant ALL with MLL rearrangements and pediatric RT ALL with hyperdiploidy."; RL Blood 103:1085-1088(2004). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, Agda Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=8180386; DOI=10.1182/blood.V83.10.2912.2912; RA Yamamoto, Kazuhito RA Seto, Masao RA Iida, Shinsuke RA Komatsu, Hirokazu RA Kamada, Nanao RA Kojima, Seiji RA Kodera, Yoshihisa RA Nakazawa, Shinpei RA Saito, Hidehiko RA Takahashi, Toshitada RA Ueda, Ryuzo RT "A reverse transcriptase-polymerase chain reaction detects RT heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities."; RL Blood 83:2912-2921(1994). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=31305009; DOI=10.1002/cam4.2356; PMCID=PMC6718581; RA Watanabe, Atsushi RA Inukai, Takeshi RA Kagami, Keiko RA Abe, Masako RA Takagi, Masatoshi RA Fukushima, Takashi RA Fukushima, Hiroko RA Nanmoku, Toru RA Terui, Kiminori RA Ito, Tatsuya RA Toki, Tsutomu RA Ito, Etsuro RA Fujimura, Junya RA Goto, Hiroaki RA Endo, Mikiya RA Look, Thomas RA Kamps, Mark P. RA Minegishi, Masayoshi RA Takita, Junko RA Inaba, Toshiya RA Takahashi, Hiroyuki RA Ohara, Akira RA Harama, Daisuke RA Shinohara, Tamao RA Somazu, Shinpei RA Oshiro, Hiroko RA Akahane, Koshi RA Goi, Kumiko RA Sugita, Kanji RT "Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to RT multiagents in induction therapy."; RL Cancer Med. 8:5274-5288(2019). // RX PubMed=35124168; DOI=10.1016/j.jsbmb.2022.106068; RA Tamai, Minori RA Kasai, Shin RA Akahane, Koshi RA Thu, Thao Nguyen RA Kagami, Keiko RA Komatsu, Chiaki RA Abe, Masako RA Watanabe, Atsushi RA Goi, Kumiko RA Miyake, Kunio RA Inaba, Toshiya RA Takita, Junko RA Goto, Hiroaki RA Minegishi, Masayoshi RA Iwamoto, Shotaro RA Sugita, Kanji RA Inukai, Takeshi RT "Glucocorticoid receptor gene mutations confer glucocorticoid RT resistance in B-cell precursor acute lymphoblastic leukemia."; RL J. Steroid Biochem. Mol. Biol. 218:106068.1-106068.12(2022). // RX PubMed=8414510; RA Iida, Shinsuke RA Seto, Masao RA Yamamoto, Kazuhito RA Komatsu, Hirokazu RA Tojo, Arinobu RA Asano, Shigetaka RA Kamada, Nanao RA Ariyoshi, Yutaka RA Takahashi, Toshitada RA Ueda, Ryuzo RT "MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a RT serine/proline rich protein homologous to MLLT1 on 19p13."; RL Oncogene 8:3085-3092(1993). // RX PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid RT phosphatase."; RL Leuk. Res. 9:537-548(1985). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=23955599; DOI=10.1038/ng.2731; RA Kon, Ayana RA Shih, Lee-Yung RA Minamino, Masashi RA Sanada, Masashi RA Shiraishi, Yuichi RA Nagata, Yasunobu RA Yoshida, Ken-ichi RA Okuno, Yusuke RA Bando, Masashige RA Nakato, Ryuichiro RA Ishikawa, Shumpei RA Sato-Otsubo, Aiko RA Nagae, Genta RA Nishimoto, Aiko RA Haferlach, Claudia RA Nowak, Daniel RA Sato, Yusuke RA Alpermann, Tamara RA Nagasaki, Masao RA Shimamura, Teppei RA Tanaka, Hiroko RA Chiba, Kenichi RA Yamamoto, Ryo RA Yamaguchi, Tomoyuki RA Otsu, Makoto RA Obara, Naoshi RA Sakata-Yanagimoto, Mamiko RA Nakamaki, Tsuyoshi RA Ishiyama, Ken RA Nolte, Florian RA Hofmann, Wolf-Karsten RA Miyawaki, Shuichi RA Chiba, Shigeru RA Mori, Hiraku RA Nakauchi, Hiromitsu RA Koeffler, Harold Phillip RA Aburatani, Hiroyuki RA Haferlach, Torsten RA Shirahige, Katsuhiko RA Miyano, Satoru RA Ogawa, Seishi RT "Recurrent mutations in multiple components of the cohesin complex in RT myeloid neoplasms."; RL Nat. Genet. 45:1232-1237(2013). // RX PubMed=29786757; DOI=10.1007/s12185-018-2474-7; RA Tomoyasu, Chihiro RA Imamura, Toshihiko RA Tomii, Toshihiro RA Yano, Mio RA Asai, Daisuke RA Goto, Hiroaki RA Shimada, Akira RA Sanada, Masashi RA Iwamoto, Shotaro RA Takita, Junko RA Minegishi, Masayoshi RA Inukai, Takeshi RA Sugita, Kanji RA Hosoi, Hajime RT "Copy number abnormality of acute lymphoblastic leukemia cell lines RT based on their genetic subtypes."; RL Int. J. Hematol. 108:312-318(2018). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=32180206; DOI=10.1007/s13577-020-00347-5; PMCID=PMC7324421; RA Kasai, Fumio RA Asou, Hiroya RA Ozawa, Midori RA Kobayashi, Kazuhiko RA Kuramitsu, Hiroyuki RA Satoh, Motonobu RA Kohara, Arihiro RA Kaneko, Yasuhiko RA Kawamura, Machiko RT "Kasumi leukemia cell lines: characterization of tumor genomes with RT ethnic origin and scales of genomic alterations."; RL Hum. Cell 33:868-876(2020). // RX PubMed=10360377; DOI=10.1038/sj.leu.2401437; RA Nakamura, Makoto RA Sugita, Kanji RA Inukai, Takeshi RA Goi, Kumiko RA Iijima, Kumiko RA Tezuka, Toshiki RA Kojika, Satoru RA Shiraishi, Kenji RA Miyamoto, Nariaki RA Karakida, Naoko RA Kagami, Keiko RA Koyama-Okazaki, Toshiko RA Mori, Taijiro RA Nakazawa, Shinpei RT "p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in RT childhood acute lymphoblastic leukemia with 11q23 translocation."; RL Leukemia 13:884-890(1999). // RX PubMed=15843827; DOI=10.1038/sj.leu.2403749; RA Hagstrom-Andersson, Anna K. RA Eden, Patrik RA Lindgren, David RA Nilsson, Jens RA Lassen, Carin RA Heldrup, Jesper RA Fontes, Magnus RA Borg, Ake RA Mitelman, Felix RA Johansson, Bertil RA Hoglund, Mattias RA Fioretos, Thoas RT "Gene expression profiling of leukemic cell lines reveals conserved RT molecular signatures among subtypes with specific genetic RT aberrations."; RL Leukemia 19:1042-1050(2005). // RX PubMed=9738977; DOI=10.1111/j.1349-7006.1998.tb03275.x; PMCID=PMC5921886; RA Takizawa, Jun RA Suzuki, Ritsuro RA Kuroda, Hiroyuki RA Utsunomiya, Atae RA Kagami, Yoshitoyo RA Joh, Tatsuroh RA Aizawa, Yoshifusa RA Ueda, Ryuzo RA Seto, Masao RT "Expression of the TCL1 gene at 14q32 in B-cell malignancies but not RT in adult T-cell leukemia."; RL Jpn. J. Cancer Res. 89:712-718(1998). // RX PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- 1. RT Carboxylic esterase."; RL Leuk. Res. 9:209-229(1985). // RX PubMed=20575032; DOI=10.1002/ajh.21738; PMCID=PMC7159455; RA Inukai, Takeshi RA Zhang, Xiu-Ru RA Kameyama, Takeshi RA Suzuki, Yukiko RA Yoshikawa, Kazuhito RA Kuroda, Itaru RA Nemoto, Atsushi RA Akahane, Koshi RA Sato, Hiroki RA Goi, Kumiko RA Nakamoto, Kazunori RA Hamada, Jun-ichi RA Tada, Mitsuhiro RA Moriuchi, Tetsuya RA Sugita, Kanji RT "A specific linkage between the incidence of TP53 mutations and type RT of chromosomal translocations in B-precursor acute lymphoblastic RT leukemia cell lines."; RL Am. J. Hematol. 85:535-537(2010). // RX PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646; RA Quentmeier, Hilmar RA Pommerenke, Claudia RA Dirks, Wilhelm Gerhard RA Eberth, Sonja RA Koeppel, Max RA MacLeod, Roderick A.F. RA Nagel, Stefan RA Steube, Klaus G. RA Uphoff, Cord C. RA Drexler, Hans Gunther RT "The LL-100 panel: 100 cell lines for blood cancer studies."; RL Sci. Rep. 9:8218.1-8218.14(2019). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=28569787; DOI=10.1038/cddis.2017.249; PMCID=PMC5520907; RA Kasai, Shin RA Furuichi, Yoshiyuki RA Ando, Norie RA Kagami, Keiko RA Abe, Masako RA Nakane, Takaya RA Goi, Kumiko RA Inukai, Takeshi RA Saitoh, Sei RA Ohno, Shinichi RA Okazaki, Shogo RA Nagano, Osamu RA Saya, Hideyuki RA Sugita, Kanji RT "Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers RT necrosis of B-precursor leukemia cells with high surface CD44 RT expression."; RL Cell Death Dis. 8:e2857.1-e2857.11(2017). // RX PubMed=16523483; DOI=10.1002/gcc.20317; RA Horsley, Sharon W. RA Mackay, Alan RA Iravani, Marjan RA Fenwick, Kerry RA Valgeirsson, Haukur RA Dexter, Tim J. RA Ashworth, Alan RA Kearney, Lyndal RT "Array CGH of fusion gene-positive leukemia-derived cell lines reveals RT cryptic regions of genomic gain and loss."; RL Genes Chromosomes Cancer 45:554-564(2006). // RX PubMed=10233379; DOI=10.1111/j.1365-2141.1999.01284.x; RA Xu, Feng RA Taki, Tomohiko RA Yang, Hong-Wei RA Hanada, Ryoji RA Hongo, Teruaki RA Ohnishi, Hiroaki RA Kobayashi, Miyuki RA Bessho, Fumio RA Yanagisawa, Masayoshi RA Hayashi, Yasuhide RT "Tandem duplication of the FLT3 gene is found in acute lymphoblastic RT leukaemia as well as acute myeloid leukaemia but not in RT myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in RT children."; RL Br. J. Haematol. 105:155-162(1999). // RX PubMed=10995006; DOI=10.1038/sj.leu.2401893; RA Iijima, Kumiko RA Sugita, Kanji RA Inukai, Takeshi RA Goi, Kumiko RA Tezuka, Toshiki RA Uno, Kanako RA Sato, Hiroki RA Kagami, Keiko RA Nakazawa, Shinpei RT "Expression of thrombopoietin receptor and its functional role in RT human B-precursor leukemia cells with 11q23 translocation or RT Philadelphia chromosome."; RL Leukemia 14:1598-1605(2000). // RX PubMed=9067587; DOI=10.1038/sj.leu.2400571; RA Uphoff, Cord C. RA MacLeod, Roderick A.F. RA Denkmann, Sabine A. RA Golub, Todd Robert RA Borkhardt, Arndt RA Janssen, Johannes W.G. RA Drexler, Hans Gunther RT "Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in RT human early B-lineage leukemia cell lines."; RL Leukemia 11:441-447(1997). // RX PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- III. RT Beta-hexosaminidase (E.C. 3.2.1.30)."; RL Leuk. Res. 9:549-559(1985). // RX PubMed=35354797; DOI=10.1038/s41467-022-29224-5; PMCID=PMC8967900; RA Leo, Isabelle Rose RA Aswad, Luay RA Stahl, Matthias RA Kunold, Elena RA Post, Frederik RA Erkers, Tom RA Struyf, Nona RA Mermelekas, Georgios RA Joshi, Rubin Narayan RA Gracia-Villacampa, Eva RA Ostling, Paivi RA Kallioniemi, Olli-Pekka RA Pokrovskaja Tamm, Katja RA Siavelis, Ioannis RA Lehtio, Janne RA Vesterlund, Mattias RA Jafari, Rozbeh RT "Integrative multi-omics and drug response profiling of childhood RT acute lymphoblastic leukemia cell lines."; RL Nat. Commun. 13:1691.1-1691.19(2022). // RX PubMed=14671638; DOI=10.1038/sj.leu.2403236; RA Drexler, Hans Gunther RA Quentmeier, Hilmar RA MacLeod, Roderick A.F. RT "Malignant hematopoietic cell lines: in vitro models for the study of RT MLL gene alterations."; RL Leukemia 18:227-232(2004). // RX PubMed=1423624; DOI=10.1016/0092-8674(92)90602-9; RA Tkachuk, Douglas Cameron RA Kohler, Sabine RA Cleary, Michael L. RT "Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal RT translocations in acute leukemias."; RL Cell 71:691-700(1992). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX PubMed=30629668; DOI=10.1371/journal.pone.0210404; PMCID=PMC6328144; RA Uphoff, Cord C. RA Pommerenke, Claudia RA Denkmann, Sabine A. RA Drexler, Hans Gunther RT "Screening human cell lines for viral infections applying RNA-Seq data RT analysis."; RL PLoS ONE 14:e0210404.1-e0210404.22(2019). // RX PubMed=20519628; DOI=10.1182/blood-2009-09-244673; RA Hirose, Kinuko RA Inukai, Takeshi RA Kikuchi, Jiro RA Furukawa, Yusuke RA Ikawa, Tomokatsu RA Kawamoto, Hiroshi RA Oram, S. Helen RA Gottgens, Berthold RA Kiyokawa, Nobutaka RA Miyagawa, Yoshitaka RA Okita, Hajime RA Akahane, Koshi RA Zhang, Xiao-Chun RA Kuroda, Itaru RA Honna, Hiroko RA Kagami, Keiko RA Goi, Kumiko RA Kurosawa, Hidemitsu RA Look, Alfred Thomas RA Matsui, Hirotaka RA Inaba, Toshiya RA Sugita, Kanji RT "Aberrant induction of LMO2 by the E2A-HLF chimeric transcription RT factor and its implication in leukemogenesis of B-precursor ALL with RT t(17;19)."; RL Blood 116:962-970(2010). // RX PubMed=22160482; DOI=10.1182/blood-2011-01-330019; RA McDermott, Sean P. RA Eppert, Kolja RA Notta, Faiyaz RA Isaac, Methvin RA Datti, Alessandro RA Al-awar, Rima RA Wrana, Jeffrey L. RA Minden, Mark David RA Dick, John Edgar RT "A small molecule screening strategy with validation on human leukemia RT stem cells uncovers the therapeutic efficacy of kinetin riboside."; RL Blood 119:1200-1207(2012). // RX PubMed=1465024; DOI=10.1016/0145-2126(92)90113-L; RA Iida, Shinsuke RA Saito, Midori RA Koyama-Okazaki, Toshiko RA Seto, Masao RA Yamamoto, Kazuhito RA Akao, Yukihiro RA Ogura, Michinori RA Suzuki, Hisamitsu RA Ariyoshi, Yutaka RA Koike, Koichi RA Nitta, Masakazu RA Takahashi, Toshitada RA Ueda, Ryuzo RA Nakazawa, Shinpei RT "Phenotypic and genotypic characterization of 14 leukemia and lymphoma RT cell lines with 11q23 translocations."; RL Leuk. Res. 16:1155-1163(1992). // RX PubMed=9529133; DOI=10.1038/sj.leu.2400951; RA Inukai, Takeshi RA Sugita, Kanji RA Iijima, Kumiko RA Goi, Kumiko RA Tezuka, Toshiki RA Kojika, Satoru RA Kagami, Keiko RA Mori, Taijiro RA Kinoshita, Akitoshi RA Suzuki, Toshio RA Koyama-Okazaki, Toshiko RA Nakazawa, Shinpei RT "Leukemic cells with 11q23 translocations express granulocyte RT colony-stimulating factor (G-CSF) receptor and their proliferation is RT stimulated with G-CSF."; RL Leukemia 12:382-389(1998). // RX PubMed=30285677; DOI=10.1186/s12885-018-4840-5; PMCID=PMC6167786; RA Tan, Kar-Tong RA Ding, Ling-Wen RA Sun, Qiao-Yang RA Lao, Zhen-Tang RA Chien, Wenwen RA Ren, Xi RA Xiao, Jin-Fen RA Loh, Xin-Yi RA Xu, Liang RA Lill, Michael RA Mayakonda, Anand RA Lin, De-Chen RA Yang, Henry He RA Koeffler, Harold Phillip RT "Profiling the B/T cell receptor repertoire of lymphocyte derived cell RT lines."; RL BMC Cancer 18:940.1-940.13(2018). //